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Introduction. Vaccination is a major tool to protect people from seasonal infections of different 
strains of influenza virus that presently infects millions of individuals worldwide. Virus genome is 
highly polymorphic, and universal vaccine that protects against permanently changing virus is still 
under development. Despite notable differences between humans and rodents in the disease course, 
immunobiology and clinical evaluations, murine infectious models remain one of the major tools to test 
approaches for influenza vaccine development. 
Materials and methods. BALB/c mice were subcutaneously immunized with 8-22-mer peptides or 
alternatively with peptide conjugated to KLH in complete Freund's adjuvant (CFA), and then received 
second immunization in three weeks with peptides and/or peptide~KLH in incomplete Freund's adjuvant 
(collaboration with the Institute of Microbiology and Virology, Kiev, Ukraine). In two weeks, titers of 
peptide-specific antibodies were measured in mouse serum. Splenocytes were in vitro stimulated with 
peptides for two days, and production of IFN-gamma, TGF-beta, IL-2, and IL-4 was assayed by ELISA. 
To test protective effect of mouse vaccination, white mice received two immunizations with a cocktail 
of selected peptides (at the Research Institute for Biological Safety Problems, Zhambulskaya oblast, 
Gvardeisky, Kazakhstan). Then mice were infected intranasally with pandemic strain A/California/7/09 
(H1N1) or with strain A/domestic goose/Pavlodar/1/05 (H5N1). Virus titers in lungs, body weight, 
mouse lethality, and histopathological evaluation for liver necrosis and lung infiltration were scored and 
analyzed. 
Results and discussion. Previously, we selected 53 peptides of the virus proteome using bio-
informatics approaches and filtered peptides for sequence conservancy and recognition by HLA of class 
I and I I . After mice immunization with groups of pooled peptides, significant immune responses were 
detected for all measured cytokines and serum antibodies. Based upon immune response screening, we 
selected six peptide groups that altogether stimulated strong anti-peptide antibody IgGAM production, 
and high peptide-specific IL-2, IL-4, and IFN-gamma responses, while TGF-beta response was zeroed 
to prevent immunosuppression. These six peptides represent hemagglutinin (362-410 aa), M2 proton 
channel (31-54 aa) and neuraminidase (21-38 aa). At the next step, we immunized mice with a cocktail 
of six selected peptides in hope to protect mice against the acute infection with influenza. Based on 
body weight dynamics, mice perfectly tolerated two immunizations with selected peptides. In vitro 
experiments confirmed no toxicity of selected peptides even at a high concentration for mammalian cells. 
Peptide cocktail demonstrated a significant protective effect upon mouse survival during infection with 
H5N1 strain of virus (p < 0.02 Student's t-test). This protective effect correlated with significantly lower 
titers of the virus in mouse lungs when compared to mice immunized with PBS-adjuvant (p < 0.019). 
Conclusions. We found combination of several conservative epitopes of viral proteome that ensure 
partial protection of rodents from otherwise killing concentration of the virus. 
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